Ivermectin Use for Cancer Prevention

Thousands of cancer patients have come to me and asked me, how do you use

ivermectin for cancer prevention?

How do you use ivermectin to reduce the risk of getting cancer over the long

term?

And to be honest, no one has the answer to that because

no one has researched ivermectin for cancer prevention.

All we can really do is hypothesize.

So if we look at the anti-cancer activity of ivermectin, we know

from anecdotal reports that even low doses of ivermectin,

like twelve milligrams a day or twenty-four milligrams a day,

in some cases

can stop cancer growth and can even shrink

tumors. I've published a number of these cases on

my

Substack, for example.

We also have anecdotal reports on fenbendazole from

Joe Tippins. Joe Tippins took a low dose of two

twenty-two milligrams a day of

fenbendazole to treat his small cell lung cancer

successfully. It was a stage four small cell lung

cancer, and he treated it

successfully, and he's been on it for seven years now.

In the early trials of mebendazole, cancer researchers were

looking at a hundred or two hundred milligrams a day

and found some success

with those low doses as well.

Now, how long would you take something like

this? Again, we don't know.

But you can look at it from the perspective of, let's say,

doing a parasite

cleanse. If you do a parasite cleanse, you might take antiparasitics

for three or four weeks, about a month.

Uh, and you would take probably low doses, as I've mentioned earlier.

Um, now you're not doing a-- just a parasite

cleanse. What you're doing is you're also killing

precancerous cells that might eventually establish into

small tumors.

So you can think of it as doing a cleanse of

precancerous cells or even cancerous cells.

And

one of the approaches that I have taken for myself is

doing a ivermectin cleanse for two months, for

example. Now, patients who have a higher risk of getting

cancer,

maybe they have family history, maybe they have genetic defects like

BRCA1, BRCA2, or maybe they've had cancer before.

They might want to take low doses of ivermectin, fenbendazole,

mebendazole for a

longer period of time, uh, or they might want to take it

indefinitely.

The sad part is that we just don't know.

We don't know because no one's done the research, and unfortunately, I don't think

anyone is going to do the research.

These kind of clinical trials, especially looking over the long term,

you would

need to look at five years or ten years, and look

at, you know, the frequency of those patients

getting cancer, the ones who have been on ivermectin,

fenben, and mebendazole,

versus those who didn't take it. And no one is going to do

that kind of research

over five or ten years. It costs a lot of money.

It takes up a lot of resources, and unfortunately,

there's just no money in it.

So all we have really are hypotheses.

Uh, patients have to understand that no one knows the answer, uh, but

we do have some good hypotheses that we can work with.